Pyramidal cell axon initial segment in Alzheimer´s disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 05 2022
Historique:
received: 06 08 2021
accepted: 09 05 2022
entrez: 24 5 2022
pubmed: 25 5 2022
medline: 27 5 2022
Statut: epublish

Résumé

The axon initial segment (AIS) is a region of the neuron that is critical for action potential generation as well as for the regulation of neural activity. This specialized structure-characterized by the expression of different types of ion channels as well as adhesion, scaffolding and cytoskeleton proteins-is subjected to morpho-functional plastic changes in length and position upon variations in neural activity or in pathological conditions. In the present study, using immunocytochemistry with the AT8 antibody (phospho-tau S202/T205) and 3D confocal microscopy reconstruction techniques in brain tissue from Alzheimer's disease patients, we found that around half of the cortical pyramidal neurons with hyperphosphorylated tau showed changes in AIS length and position in comparison with AT8-negative neurons from the same cortical layers. We observed a wide variety of AIS alterations in neurons with hyperphosphorylated tau, although the most common changes were a proximal shift or a lengthening of the AISs. Similar results were found in neocortical tissue from non-demented cases with neurons containing hyperphosphorylated tau. These findings support the notion that the accumulation of phospho-tau is associated with structural alterations of the AIS that are likely to have an impact on normal neuronal activity, which might contribute to neuronal dysfunction in AD.

Identifiants

pubmed: 35610289
doi: 10.1038/s41598-022-12700-9
pii: 10.1038/s41598-022-12700-9
pmc: PMC9130508
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8722

Subventions

Organisme : Alzheimer's Association
ID : ZEN-15-321663
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

J Neurotrauma. 2013 May 1;30(9):741-51
pubmed: 23025758
Cereb Cortex. 2009 Jan;19(1):41-54
pubmed: 18440949
J Cell Biol. 2002 Jan 21;156(2):337-48
pubmed: 11807096
Neurobiol Dis. 2017 Jan;97(Pt A):11-23
pubmed: 27793637
J Alzheimers Dis. 2007 Dec;12(4):365-75
pubmed: 18198423
Brain Struct Funct. 2015 Mar;220(2):869-84
pubmed: 24363122
Neuron. 2007 Aug 16;55(4):633-47
pubmed: 17698015
Mol Neurodegener. 2016 Jun 29;11(1):47
pubmed: 27356871
Brain Struct Funct. 2017 Aug;222(6):2831-2853
pubmed: 28285370
J Neurosci. 2011 Nov 30;31(48):17637-48
pubmed: 22131424
Nature. 2010 Jun 24;465(7301):1070-4
pubmed: 20543823
Neuron. 2010 Dec 22;68(6):1067-81
pubmed: 21172610
Int J Alzheimers Dis. 2012;2012:578373
pubmed: 22675648
J Biol Chem. 2017 Jul 21;292(29):12192-12207
pubmed: 28536263
J Neurosci. 2015 May 6;35(18):7272-86
pubmed: 25948275
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9757-62
pubmed: 26195803
Dementia. 1996 Jul-Aug;7(4):177-81
pubmed: 8835879
Arch Neurol. 2009 Apr;66(4):435-40
pubmed: 19204149
J Alzheimers Dis. 2019;69(1):277-288
pubmed: 30958368
Acta Neuropathol. 2017 May;133(5):717-730
pubmed: 28091722
J Neurosci. 2007 Mar 14;27(11):2896-907
pubmed: 17360912
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):510-4
pubmed: 24368848
Brain. 2013 Jun;136(Pt 6):1913-28
pubmed: 23715095
Eur J Neurosci. 2011 Nov;34(10):1609-19
pubmed: 22103418
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
J Cell Biol. 1985 Oct;101(4):1371-8
pubmed: 3930508
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14271-6
pubmed: 25232037
Neuroreport. 1994 Nov 21;5(17):2358-62
pubmed: 7533559
Science. 2010 May 14;328(5980):906-9
pubmed: 20466935
J Histochem Cytochem. 1996 Oct;44(10):1167-71
pubmed: 8813082
Epilepsy Res. 2013 Aug;105(3):272-9
pubmed: 23602553
Acta Pharmacol Sin. 2016 Jan;37(1):75-81
pubmed: 26687934
Stroke. 2013 Jan;44(1):182-9
pubmed: 23233385
Acta Neuropathol. 1994;87(6):554-67
pubmed: 7522386
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
J Neurosci. 1987 Oct;7(10):3142-53
pubmed: 2444675
J Cell Biol. 2001 Nov 26;155(5):739-46
pubmed: 11724816
Exp Neurol. 2016 Jul;281:93-8
pubmed: 27109181
Nat Neurosci. 2008 Feb;11(2):178-86
pubmed: 18204443
Neural Plast. 2016;2016:6808293
pubmed: 27493806
J Neurosci. 2013 Jan 23;33(4):1651-9
pubmed: 23345237
Front Cell Neurosci. 2017 Nov 06;11:332
pubmed: 29170630
Neurosci Lett. 1995 Apr 21;189(3):167-9
pubmed: 7624036
Cell Rep. 2015 Nov 10;13(6):1233-1245
pubmed: 26526995
J Neurosci. 2003 Mar 15;23(6):2306-13
pubmed: 12657689
Exp Neurol. 2010 Jun;223(2):385-93
pubmed: 19665462
Neuroscience. 2010 Jun 30;168(2):323-34
pubmed: 20394726
Science. 2007 May 4;316(5825):750-4
pubmed: 17478722
Nature. 2010 Jun 24;465(7301):1022-3
pubmed: 20577202
J Cell Biol. 2008 Nov 17;183(4):635-40
pubmed: 19001126
J Neurosci. 2013 Jul 31;33(31):12887-97
pubmed: 23904623
EMBO J. 2011 Oct 18;30(23):4825-37
pubmed: 22009197
J Neurosci. 2009 Oct 21;29(42):13242-54
pubmed: 19846712
J Neurosci. 1988 Jun;8(6):1846-51
pubmed: 3133453
J Alzheimers Dis. 2012;29(4):841-52
pubmed: 22337828
J Neurosci. 1996 Sep 15;16(18):5727-40
pubmed: 8795628
Front Neuroanat. 2014 Mar 11;8:11
pubmed: 24653680
Acta Neuropathol. 2002 Jan;103(1):26-35
pubmed: 11837744
Nature. 2010 Jun 24;465(7301):1075-8
pubmed: 20543825
Front Cell Neurosci. 2016 Oct 25;10:250
pubmed: 27826229

Auteurs

Alejandro Antón-Fernández (A)

Department of Functional and Systems Neurobiology, Instituto Cajal, CSIC, Madrid, Spain.
Laboratorio Cajal de Circuitos Corticales (CTB), Universidad Politécnica de Madrid, Madrid, Spain.
Department of Molecular Neuropathology, Centro de Biología Molecular Severo Ochoa, CBMSO, CSIC-UAM, Madrid, Spain.

Gonzalo León-Espinosa (G)

Laboratorio Cajal de Circuitos Corticales (CTB), Universidad Politécnica de Madrid, Madrid, Spain. gonzalo.leonespinosa@ceu.es.
Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660, Boadilla del Monte, Madrid, Spain. gonzalo.leonespinosa@ceu.es.

Javier DeFelipe (J)

Department of Functional and Systems Neurobiology, Instituto Cajal, CSIC, Madrid, Spain.
Laboratorio Cajal de Circuitos Corticales (CTB), Universidad Politécnica de Madrid, Madrid, Spain.
CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.

Alberto Muñoz (A)

Department of Functional and Systems Neurobiology, Instituto Cajal, CSIC, Madrid, Spain.
Laboratorio Cajal de Circuitos Corticales (CTB), Universidad Politécnica de Madrid, Madrid, Spain.
Department of Cell Biology, Universidad Complutense de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH